Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibody-Drug Conjugates in Uro-Oncology.
Sigorski D, Różanowski P, Iżycka-Świeszewska E, Wiktorska K. Sigorski D, et al. Among authors: rozanowski p. Target Oncol. 2022 May;17(3):203-221. doi: 10.1007/s11523-022-00872-3. Epub 2022 May 14. Target Oncol. 2022. PMID: 35567672 Review.
HER-3 expression in HER-2-amplified breast carcinoma.
Czopek J, Pawlęga J, Fijorek K, Püsküllüoğlu M, Różanowski P, Okoń K. Czopek J, et al. Among authors: rozanowski p. Contemp Oncol (Pozn). 2013;17(5):446-9. doi: 10.5114/wo.2013.38564. Epub 2013 Nov 14. Contemp Oncol (Pozn). 2013. PMID: 24596534 Free PMC article.
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Xu DZ, Hernandez S, Liu J, Huang C, Mulla S, Wang Y, Lim HY, Zhu AX, Cheng AL; IMbrave150 Investigators. Finn RS, et al. N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745. N Engl J Med. 2020. PMID: 32402160 Clinical Trial.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators. Powles T, et al. Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21. Lancet Oncol. 2020. PMID: 32971005 Clinical Trial.
Prophphylactic bilateral salpingngectomy: why is it worthwhile?
Kurek Ł, Jabłoński K, Góralska N, Żuchlińska J, Stelmaszczyk Ł, Różanowski P. Kurek Ł, et al. Among authors: rozanowski p. Dev Period Med. 2018;22(4):390-395. doi: 10.34763/devperiodmed.20182204.390395. Dev Period Med. 2018. PMID: 30636239 Free PMC article. English.